Investigation of the Relationship Between Cardiovascular Biomarkers and Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients

Overview

Journal J Pers Med

Date 2022 Apr 23

PMID 35455752

Authors

Ping-Ruey Chou

Pei-Yu Wu

Ping-Hsun Wu

Teng-Hui Huang

Jiun-Chi Huang

Szu-Chia Chen

Su-Chu Lee

Mei-Chuan Kuo

Yi-Wen Chiu

Ya-Ling Hsu

Jer-Ming Chang

Shang-Jyh Hwang

Affiliations

Soon will be listed here.

Abstract

Brachial−ankle pulse wave velocity (baPWV) and cardiovascular (CV) biomarkers are correlated with clinical cardiovascular diseases (CVDs) in patients with kidney disease. However, limited studies evaluated the relationship between baPWV and CV biomarkers in hemodialysis patients. This study investigated the relationship between circulating CV biomarkers and baPWV in patients on hemodialysis. Hemodialysis patients were enrolled between August 2016 and January 2017 for the measurement of baPWV, traditional CV biomarkers, including high-sensitivity troponin-T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), and novel CV biomarkers, including Galectin-3, Cathepsin D, placental growth factor, Endocan-1, and Fetuin-A. The independent association was assessed by multivariate-adjusted linear regression analysis to control for potential confounders. The final analysis included 176 patients (95 men and 81 women) with a mean age of 60 ± 11 y old. After adjusting for age and sex, hsTnT (p < 0.01), NT-proBNP (p = 0.01), Galectin-3 (p = 0.03), and Cathepsin D (p < 0.01) were significantly directly correlated with baPWV. The direct correlation with baPWV existed in multivariable linear regression models with a β of 0.1 for hsTnT and 0.1 for Cathepsin D. The direct relationship between baPWV and CV biomarkers, particularly with hsTnT and Cathepsin D, may be helpful for risk stratification of hemodialysis patients.

Citing Articles

Cardiac Troponin Serum Concentration Measurement Is Useful Not Only in the Diagnosis of Acute Cardiovascular Events.

Jakubiak G J Pers Med. 2024; 14(3).

PMID: 38540973 PMC: 10971222. DOI: 10.3390/jpm14030230.

Association of serum galectin-3 levels with mortality and cardiovascular disease outcomes in hemodialysis patients: a systematic review and dose-response meta-analysis.

Bellos I, Marinaki S, Lagiou P, Benetou V Int Urol Nephrol. 2024; 56(8):2755-2767.

PMID: 38519721 PMC: 11266241. DOI: 10.1007/s11255-024-04026-4.

New Methodology of Human Health Express Diagnostics Based on Pulse Wave Measurements and Occlusion Test.

Davydov R, Zaitceva A, Davydov V, Isakova D, Mazing M J Pers Med. 2023; 13(3).

PMID: 36983623 PMC: 10052938. DOI: 10.3390/jpm13030443.

References

Otsuka K, Nakanishi K, Shimada K, Nakamura H, Inanami H, Nishioka H . Ankle-brachial index, arterial stiffness, and biomarkers in the prediction of mortality and outcomes in patients with end-stage kidney disease. Clin Cardiol. 2019; 42(7):656-662. PMC: 6605000. DOI: 10.1002/clc.23188. View

Sharma U, Pokharel S, van Brakel T, van Berlo J, Cleutjens J, Schroen B . Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004; 110(19):3121-8. DOI: 10.1161/01.CIR.0000147181.65298.4D. View

Zhou Z, Ji Y, Ju H, Chen H, Sun M . Circulating Fetuin-A and Risk of All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Front Physiol. 2019; 10:966. PMC: 6682591. DOI: 10.3389/fphys.2019.00966. View

Kuang D, Li C, Kuok U, Cheung K, Lio W, Xin J . Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao. BMC Nephrol. 2012; 13:143. PMC: 3531255. DOI: 10.1186/1471-2369-13-143. View

Cecelja M, Chowienczyk P . Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc Dis. 2013; 1(4). PMC: 3738327. DOI: 10.1258/cvd.2012.012016. View

Roman M, Ganau A, Saba P, Pini R, Pickering T, Devereux R . Impact of arterial stiffening on left ventricular structure. Hypertension. 2000; 36(4):489-94. DOI: 10.1161/01.hyp.36.4.489. View

Yang R, Rabinovich G, Liu F . Galectins: structure, function and therapeutic potential. Expert Rev Mol Med. 2008; 10:e17. DOI: 10.1017/S1462399408000719. View

Liu J, Sukhova G, Sun J, Xu W, Libby P, Shi G . Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24(8):1359-66. DOI: 10.1161/01.ATV.0000134530.27208.41. View

Pawlak K, Mysliwiec M, Pawlak D . Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Clin Biochem. 2015; 48(6):425-30. DOI: 10.1016/j.clinbiochem.2015.01.006. View

10.

Matsui M, Samejima K, Takeda Y, Tanabe K, Morimoto K, Okamoto K . Prognostic Impact of Placental Growth Factor on Mortality and Cardiovascular Events in Dialysis Patients. Am J Nephrol. 2015; 42(2):117-25. DOI: 10.1159/000439187. View

11.

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

12.

Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, Ioakeimidis N, Stefanadis C . Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012; 60(2):556-62. DOI: 10.1161/HYPERTENSIONAHA.112.194779. View

13.

Hsu B, Wang C, Lai Y, Tsai J . Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5. Toxins (Basel). 2021; 13(8). PMC: 8402460. DOI: 10.3390/toxins13080532. View

14.

Feistritzer H, Reinstadler S, Klug G, Kremser C, Rederlechner A, Mair J . N-terminal pro-B-type natriuretic peptide is associated with aortic stiffness in patients presenting with acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2015; 5(8):560-567. DOI: 10.1177/2048872615610866. View

15.

Vallianou N, Mitesh S, Gkogkou A, Geladari E . Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?. Curr Cardiol Rev. 2018; 15(1):55-63. PMC: 6367692. DOI: 10.2174/1573403X14666180711124825. View

16.

Zhang Q, Yin K, Zhu M, Lin X, Fang Y, Lu J . Galectin-3 is associated with arterial stiffness among hemodialysis patients. Biomark Med. 2019; 13(6):437-443. DOI: 10.2217/bmm-2018-0488. View

17.

Jung J, Chae Y, Lee D, Cho Y, Ko M, Park S . Changes in whole blood viscosity during hemodialysis and mortality in patients with end-stage renal disease. Clin Hemorheol Microcirc. 2016; 65(3):285-297. DOI: 10.3233/CH-16183. View

18.

Madrigal-Matute J, Lindholt J, Fernandez-Garcia C, Benito-Martin A, Burillo E, Zalba G . Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis. J Am Heart Assoc. 2014; 3(4). PMC: 4310363. DOI: 10.1161/JAHA.114.000785. View

19.

Matsushita K, Sang Y, Ballew S, Astor B, Hoogeveen R, Solomon S . Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study. Arterioscler Thromb Vasc Biol. 2014; 34(8):1770-7. PMC: 4172337. DOI: 10.1161/ATVBAHA.114.303465. View

20.

Hyun Y, Kim H, Oh K, Ahn C, Park S, Chae D . Arterial Stiffness as a Risk Factor for Subclinical Coronary Artery Calcification in Predialysis Chronic Kidney Disease: From the KNOW-CKD Study. Kidney Blood Press Res. 2019; 44(3):426-434. DOI: 10.1159/000499648. View